Company: HURA
Filing Date: 2025-05-23
Form Type: 424B3
Source: 0001193125-25-125499
Chunk: 485

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-23
Form: 424B3
Chunk 485
---
 the grant.

Interest Expense.From December 2023 to September 2024, as part of TuHURA’s private placement financing under which TuHURA
offered and sold convertible promissory note (the “TuHURA Notes”), TuHURA issued convertible notes totaling $31,253,000. The convertible notes included interest at 20% per annum, accretion to maturity date, and amortization of debt
discount. Upon the completion of the Kintara Merger, all principal and accrued and unpaid interest and make-whole amounts under the TuHURA Notes automatically converted into shares of TuHURA Common Stock at a conversion price $3.80 per share of
TuHURA Common Stock. There was no cash paid for interest in the TuHURA Notes.

Interest Income.For the years ended
December 31, 2024 and 2023, interest income was earned on deposits at various banks.

Change in fair value of derivative liability.For the year ended December 31, 2024, there was a loss of $0.3 million associated with the bifurcated embedded derivative liability related to the make-whole premium on the TuHURA Notes.

Preferred Stock Series A cash dividend.The holder of TuHURA’s Series A Preferred Stock received dividends payable
quarterly in arrears, at an annual rate of 3% of the Series A Stated Value.

Warrant modification.For the year ended
December 31, 2024, there was a $1.0 million deemed dividend due to extending the exercise period on certain of the Series A Warrants for an additional six months.

Liquidity and Capital Resources

TuHURA
has incurred net losses and negative cash flows from operations since its inception and TuHURA anticipate that it will continue to incur net losses for the foreseeable future. TuHURA incurred net losses of $22.6 million and $29.3 million for
the years ended December 31, 2024, and 2023, respectively, and used $14.7 million and $12.0 million of cash from its operating activities for the years ended December 31, 2024, and 2023, respectively. As of December 31, 2024, TuHURA had an
accumulated deficit of $111.1 million. The $29.3 million loss for the year ended December 31, 2023, included the expensing of the entire $16.2 million purchase price for the